Christopher Everett, MD
Vascular Surgery · Watkinsville, GANPI 1396878823
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Globus Medical accounts for 68.5% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2023 at $14,762 and has fallen 96.6% since, to $509 in 2025.
Across 180 payments — averaging $113.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$14K
- Centinel Spine, LLC$1K
- Johnson & Johnson$657
- Organogenesis Inc.$589
- W. L. Gore & Associates, Inc.$497
- Polynovo North America LLC$470
- plus $3K from 30 others
What the payments were for
- Consulting fees$5,28826%
- Speaking & faculty fees$8,50042%
- Travel & lodging$1,4077%
- Food & beverage$5,19125%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 14 | $13,969 |
| Centinel Spine, LLC | 2 | $1,250 |
| Johnson & Johnson | 42 | $657 |
| Organogenesis Inc. | 20 | $589 |
| W. L. Gore & Associates, Inc. | 19 | $497 |
| Polynovo North America LLC | 4 | $470 |
| Endologix LLC | 2 | $459 |
| Penumbra, Inc. | 5 | $400 |
| Kerecis Limited | 3 | $348 |
| Angiodynamics, Inc. | 5 | $258 |
| Silk Road Medical, Inc. | 6 | $195 |
| Lemaitre Vascular, Inc. | 4 | $193 |
| Boston Scientific | 7 | $177 |
| Tactile Systems Technology Inc | 9 | $162 |
| Inari Medical, Inc. | 2 | $97 |
| Getinge USA Sales, LLC | 1 | $67 |
| Philips North America LLC | 1 | $57 |
| Shockwave Medical, Inc | 1 | $52 |
| Cashflow Solutions, LLC | 8 | $50 |
| Cardiva Medical, Inc. | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Siemens Medical Solutions USA, Inc. | 2 | $42 |
| Neuros Medical, Inc. | 2 | $38 |
| Smith+Nephew | 2 | $36 |
| Medtronic(2 entities) | 2 | $30 |
| Imperative Care, Inc | 1 | $28 |
| AstraZeneca | 1 | $23 |
| Atricure, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $23 |
| BD | 1 | $21 |
| Access Pro Medical, LLC | 1 | $20 |
| Truvic Medical, Inc. | 1 | $19 |
| Argon Medical Devices, Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $9 |
| Flowphysix Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALIF$12,619
- STALIF M FLX$1,250
- Kerecis Omega3 Marigen$807
- Kerecis Omega3 SurgiClose$583
- ALIF Instruments (Universal)$479
- Alto Abdominal Stent Graft System$446
- ALIF Retractor$425
- Novosorb BTM$233
- CALIBER$204
- XARELTO$193
- ExcelsiusGPS Robotic Navigation System$174
- VIABAHN VBX Balloon Expandable Endoprosthesis$149
- Penumbra System$145
- Kerecis Omega3 GraftGuide$138
- Indigo System$134
- ENROUTE Transcarotid Neuroprotection System$106
- ENROUTE Transcarotid Stent System$106
- ENHANCE Transcarotid Peripheral Access Kit$106
- ENROUTE 0.014 Guidewire$106
How this compares
$20,385 in reported general payments places this provider in the 80th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 331 | $249,929 |
| EliquisApixaban | 82 | $52,596 |
| ClopidogrelClopidogrel Bisulfate | 102 | $1,131 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $383 |
| Cilostazol | 22 | $342 |
| Atorvastatin Calcium | 18 | $253 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $657 | $249,929331 claims |
| PfizerEliquis | $13 | $52,59682 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Watkinsville
- Siddharth PatelAtlanta$303K
- Juan AyerdiColumbus$130K
- Albert RichardsonThomasville$103K
- Walaya Methodius-RayfordAtlanta$79K
- Eric MartinFort Gordon$64K
- William JordanAugusta$64K
- Alykhan LalaniMarietta$64K
- Charles MoomeyGainesville$52K
- Suman AnnambhotlaGainesville$48K
- Andrew UnzeitigAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.